JPRN-UMIN000009508招募中未知
Prevention of TaT1 bladder cancer by BCG instillation: Induction alone versus induction and maintenance - Randomized control study of prevention bladder cancer recurrence between BCG induction alone and BCG induction + maintenance
Department of Urology and Andrology, Kansai Medical university0 个研究点目标入组 160 人开始时间: 2012年12月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) first diagnosed Ta bladder cancer, and solitary, and less than 1cm, and urine cytology negative, and with CIS (carcinoma in situ) 2) past history of BCG instillation 3)1) error correction Urine cytology positive after TUR-Bt is excluded. pTa and solitary is excluded. With CIS is excluded.
研究者
相似试验
招募中
不适用
To investigate whether rinsing the bladder with chemotherapy right before an operation that removes the kidney and ureter because of a malignant tumor is effective to reduce the risk of a subsequent bladder tumorNL-OMON24959Erasmus university Medical Center170
Unknown
不适用
Skipping BCG for T1a Urinary Bladder Tumor.Superficial Bladder Cancer t1aNCT04298073Assiut University43
终止
不适用
Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral ResectionBladder CarcinomaNCT02202044University of Colorado, Denver13
进行中（未招募）
1 期
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLArothelial cancerCTIS2024-510865-41-00Aarhus Universitetshospital282
进行中（未招募）
不适用
TREATMENT OF NON-INVASIVE BLADDER CANCER WITH HIGH RISK OF RECURRENCE – BLUE LIGHT CYSTOSCOPY WITH CHEMOTHERAPYbladder cancer (non-invasive Ta urothelial bladder cancer)EUCTR2012-000559-15-FIFinnBladder